BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 30, 2018
View Archived Issues
Cutting carb clutter could transform diabetes treatment
Read More
Patient enrollment ongoing in phase I study of EHP-101
Read More
Oncorus nominates lead clinical candidate
Read More
FF-10850, a novel liposomal topotecan with improved preclinical PK, safety and antitumor effects
Read More
Morphogen-IX names clinical candidate for PAH
Read More
miR 1249-5p identified as novel biomarker in NASH
Read More
New palbociclib-resistant luminal A breast cancer PDX model from a clinically resistant patient
Read More
New animal models of prostate cancer designed for immuno-oncology research
Read More
Relafalk approved by the European decentralized procedure for treatment of travelers' diarrhea
Read More
Pulmocide initiates phase II study of PC-945
Read More
BDP-9066 significantly increases survival and prevents radiation-induced infiltration of GBM in vivo
Read More
Phase I results reported for EBV-specific T-cell therapy in progressive multiple sclerosis
Read More
Takeda describes new BRD4 BD2 domain inhibitors
Read More
Transitional endoplasmic reticulum ATPase inhibitors identified at the University of Pittsburgh
Read More
Positive preliminary phase I data presented for TransCon CNP
Read More
The Warner Babcock Institute for Green Chemistry patents beta-amyloid inhibitors
Read More
Genetics of ADHD correlates with health risk behavior
Read More
KCNQ2/3 channel activators patented by Knopp Biosciences
Read More
Forge Therapeutics presents bacterial lpxC inhibitors
Read More
Phase III clinical study of Fycompa monotherapy meets primary endpoint
Read More
Takhzyro subcutaneous injection approved in Europe for the preventive treatment of HAE
Read More
Precedex approved for use in pediatric patients in Japan
Read More
Positive topline data presented from ENLIGHTEN-2 phase III study of ALKS-3831
Read More
Positive phase II data presented, initiation of phase III pemphigus program announced for PRN-1008
Read More
First patient enrolled in phase III study of JZP-258 for the treatment of idiopathic hypersomnia
Read More
